Browse the full record of transactions filed by 김일중, Chief Executive Officer. Insider active across 2 companies, notably 바이오노트. In total, 17,943 filings have been recorded. Activity tracked since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Kim Il-jung is the Executive Director at BioNote, where he plays a key role in managing operations and strategic development. With extensive experience in the sector, he oversees projects and ensures process efficiency. His leadership is crucial for the success of BioNote.